UNSPSC 51392607: Metaraminol tartrate

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H13NO2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZC4202M9P3, chemically known as benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)- but more generally known as metaraminol bitartrate, which bears US NIH Compound Identifier 5906. European Medicines Agency schedules Metaraminol bitartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03194MIG.

Most nations, for tariff and trade purposes, schedule metaraminol tartrate under HS 29399900 and SITC 54149. SMILES: C[C@@H]([C@@H](C1CCCC(C1)O)O)N.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51392607 Metaraminol tartrate is a Commodity code, but the recent state and local procurement activity tagged under it does not align with the code's pharmaceutical scope. Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems—emergency opioid-reversal medication and harm-reduction equipment—rather than metaraminol tartrate, a cardiovascular agent. The mismatch suggests either a tagging error in the county's procurement system or that the code is being used as a catch-all for emergency pharmaceutical and medical supply procurement that falls outside tighter commodity classifications. State and local buyers are using this code to solicit health-department and community-health drug and equipment purchases, though the single recent opportunity provides limited visibility into the breadth of issuing bodies or the consistency of coding practice across jurisdictions.

Seminole County, Florida represents the only recent activity visible under this code. The county's IFB 60459723LAS, posted June 30, 2026, sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The contract included a two-year initial term with a one-year renewal option, E-Verify and drug-free workplace compliance, and potential FEMA funding triggering federal environmental and audit requirements. Vendors bore all shipping and delivery costs. Without additional recent opportunities from other states or issuing bodies, geographic concentration and the mix of potential buyers remain unclear.